GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

On Friday, the U.S. Food and Drug Administration (FDA) approved AstraZeneca Plc’s (NASDAQ:AZN) Datroway (datopotamab ...

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.

The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication ...

A new advanced form of treatment for one of the deadliest cancers worldwide, pancreatic cancer, may be on its way, research ...

Hill’s Pet Nutrition is sponsoring the VMX Sunday Spectacular so join them in the Expo Hall at the VMX Main Stage from 7:30 to 9:30 PM Sunday, January 26, 2025, to see Acrobatic Art with HeART, a ...

GSK plc GSK announced that the European Commission has granted approval for the expanded use of Jemperli (dostarlimab) plus ...

"EC approves GSK’s Jemperli-chemo combo for endometrial cancer" was originally created and published by Pharmaceutical ...

A new treatment for the most common form of breast cancer has boosted cure rates in a major international trial.

DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.

According to Nice, osimertinib can help stop cancer from returning after surgery by targeting cells that have specific ...